GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Laboratorios Richmond SACIF RICH.BA · ARS

Health Care · Buenos Aires · 🇦🇷 Argentina

Compare

1,395.00

+7.31%

Close of 6 Nov 2026, in ARS

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Laboratorios Richmond SACIF

Its shares trade on Buenos Aires under the ticker RICH.BA. It has been listed since 22 December 2017. In the fiscal year to 31 December 2024, it reported revenue of ARS 91.79bn and net income of ARS 23.85bn. At that date it held total assets of ARS 260.15bn and shareholders' equity of ARS 64.30bn.

Laboratorios Richmond SACIF manufactures pharmaceutical products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2017-12-22. The firm's product categories include: Antiviral, under the brands Ciganclor, Lazinevir, Leuzan, Mivuten, Probirase, Protease, Selmivir, Trivenz, Virontar, Virontar N, Virontar 600, Vuclodir, Zepril, Zetavudin, and Zetrotax; Oncologi and Oncohematologic, under the brands Bemux, Capecit, Doxetal, Drifen, Espasevit, Fontrax, Gezt, and Monofer, among others; Cardiovascular, under the brands Amze 5, Amze 10, Antiplaq, Bilip 10, Bilip 20, Tacardia, and Timezol 20, among others; Neuropsychiatric, under the brands Dalam 15, Dolofrix 10, Donepes 5, and Prilben 10, among others, as well as Hospital, under the brands Amidiaz, Dalam, and Fentax, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
22 Dec 2017

Leadership

Pay as last reported

  • Sr. Marcelo Ruben FigueirasChairman of the Board, since 2018
  • Sr. Juan Manuel ArtolaDirector
  • Sr. Ricardo Jose BerteroDirector
  • Sr. R.A. Patricio CarballesDirector
  • Sra. Maria Laura LeguizamonDirector
  • Sr. Roberto PersicoDirector, since 2022
  • Sr. Daniel Jorge RazettoDirector, since 2023
  • Sra. Elvira Beatriz ZiniDirector
  • Sr. Jorge Luis ColomboTrustee, since 2024
  • Sr. Daniel Ricardo FariasTrustee
  • Sr. Santiago LizzoliTrustee, since 2024
  • Sr. Ruben Jorge AlvarezIR Contact Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
61
Environment
42
Social
70
Governance
70
Women in the workforce
42%
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Laboratorios Richmond SACIF possesses several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Laboratorios Richmond SACIF also faces some weaknesses:

Opportunities

  • There are several opportunities available for Laboratorios Richmond SACIF to leverage its strengths and enhance growth:

Threats

  • Laboratorios Richmond SACIF faces certain threats that may impact its business operations:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.